Odylia Therapeutics
Business Services · Georgia, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1447 Peachtree St NE Ste 700, Atlanta, G...Phone Number
(678) 621-2416Website
www.odylia.orgRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Odylia Therapeutics
Odylia Therapeutics is a nonprofit biotech organization focused on developing therapies for rare diseases that currently lack available treatments. By utilizing a nonprofit drug development model, Odylia aims to overcome economic barriers and accelerate the drug development process, ultimately benefiting the underserved rare disease patient community. The company integrates scientific knowledge, operational excellence, and technological innovation to provide hope and improved health outcomes for patients. Odylia collaborates with patient groups to empower their drug development efforts and relies on contributions from various donors to support its mission.Explore more
Odylia Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Odylia Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Odylia Therapeutics is spiking on competitors!
Check if Odylia Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Odylia Therapeutics
Product Launch: Get notified when Odylia Therapeutics launches new products
Website visits: Recent activity has been detected on your website
Click to see if Odylia Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Odylia Therapeutics has new funding data
Earning: See what the market has to say on Odylia Therapeutics recently announced quarterly report
Odylia Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Odylia Therapeutics
Find more new buyers
Compare Similar Companies to Odylia Therapeutics
Compare insights from companies similar to Odylia Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Odylia Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Odylia Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Odylia Therapeutics.
Odylia Therapeutics Tech Stack
A closer look at the technologies used by Odylia Therapeutics
See more technologies
Odylia Therapeutics News & Media
Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event
Industry leaders gather to discuss innovative solutions for accelerating the development of therapeutics Industry leaders gather to discuss innovative solutions for accelerating the development of therapeuticsOdylia Therapeutics Announces Appointment of Two New Members to Board of Directors
ATLANTA, Aug. 18, 2022 /PRNewswire/ -- Odylia Therapeutics, a nonprofit biotechnology company focused on the development of treatments for people living with rare diseases, today announced the appointments of Sharon M. Walker, Ph.D., J.D., and Brian Fenton to its Board of Directors. "As...Ashley Winslow Joins Nonprofit Biotech Odylia Therapeutics as Chief Scientific Officer
ATLANTA, Nov. 5, 2019 /PRNewswire/ -- Ashley Winslow, Ph.D, joins Odylia Therapeutics as Chief Scientific Officer. Dr. Winslow will oversee scientific operations and strategy development with a focus on expanding partnerships to enable Odylia to change the way gene therapies are brought...Gregory Robinson joins Nonprofit Biotech Odylia Therapeutics Advisory Board
ATLANTA, Oct. 1, 2019 /PRNewswire/ -- Gregory Robinson, Ph.D., joins the Advisory Board of Odylia Therapeutics, a nonprofit biotech dedicated to bringing treatments for rare disease to patients. He is the Chief Science Officer at Akouos and brings to Odylia extensive biotech experience in...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Odylia Therapeutics
Sign Up For FreeTo access detailed company insights
Odylia Therapeutics is a nonprofit biotech organization focused on developing therapies for rare diseases that currently lack available treatments. By utilizing a nonprofit drug development model, Odylia aims to overcome economic barriers and accelerate the drug development process, ultimately benefiting the underserved rare disease patient communi... Read More
